glp 1 optic nerve Global Study Links GLP-1 Drugs to Various Nerve, Retinal AEs 👁️ What is NAION and

Ghashghaei N et al

Discover how once-monthly maridebart cafraglutide for the treatment of obesity works, its clinical trial evidence, potential eligibility criteria, side effects, and the pathway to NHS access if approved by UK regulators.

Prednisone can save lives but may cause osteoporosis, adrenal suppression, and mood swings

PlexusDx offers personalized alternatives and medical guidance to help you lose weight safely while protecting your child

Semaglutide loses 15% body weight

Today, we announced our investigational glucagon/GLP-1 dual receptor agonist achieved key measures of success at 48 weeks in our IMPACT Phase 2b trial and recent interactions with the FDA have resulted in alignment on the parameters for a registrational Phase 3 trial